1 completed, 1 unknown. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Daewoong Bio Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease Choline Alfoscerate 400mg, Placebo - Alzheimer Disease | Phase 4 | Unknown | Daewoong Bio Inc. | 630 | 2022-01-20 | 2024-03-21 |
| Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects Single dose of rhEGF 10mcg/ml or placebo, Single dose of rhEGF 50mcg/ml or placebo, Single dose of rhEGF 100mcg/ml or placebo - Dry Eye Syndromes | Phase 1 | Completed | Daewoong Bio Inc. | 48 | 2019-03-29 | 2022-02-02 |
Alzheimer Disease (1) · Dry Eye Syndromes (1)
South Korea (2)